Research Summary
Parkinson's disease drugs are medications prescribed to individuals diagnosed with Parkinson's disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain. These drugs are primarily aimed at alleviating the motor symptoms of the condition, which include tremors, muscle rigidity, and bradykinesia (slowness of movement). The most commonly prescribed class of drugs for Parkinson's disease are levodopa medications, which are converted to dopamine in the brain to help replenish the deficient neurotransmitter. Other drug classes, such as dopamine agonists, MAO-B inhibitors, and COMT inhibitors, are also used to manage symptoms and extend the effectiveness of levodopa. While these drugs can provide significant relief from the motor symptoms, they do not cure Parkinson's disease, and their use may be tailored to each patient's specific needs and stage of the disease.
According to DIResearch's in-depth investigation and research, the global Parkinson Disease Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Parkinson Disease Drug include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, Valeant, H.Lundbeck, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Parkinson Disease Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Parkinson Disease Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Parkinson Disease Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Parkinson Disease Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Parkinson Disease Drug Include:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
Valeant
H.Lundbeck
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Parkinson Disease Drug Product Segment Include:
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Others
Parkinson Disease Drug Product Application Include:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Parkinson Disease Drug Industry PESTEL Analysis
Chapter 3: Global Parkinson Disease Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Parkinson Disease Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Parkinson Disease Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Parkinson Disease Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Parkinson Disease Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Parkinson Disease Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 Parkinson Disease Drug Product by Type 1.2.1 Global Parkinson Disease Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Sinemet-CR 1.2.3 Trastal 1.2.4 Madopar 1.2.5 COMT Inhibitor 1.2.6 Others 1.3 Parkinson Disease Drug Product by Application 1.3.1 Global Parkinson Disease Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Under 40 Years Old 1.3.3 40-65 Years Old 1.3.4 Above 65 Years Old 1.4 Global Parkinson Disease Drug Market Revenue Analysis (2019-2030) 1.5 Parkinson Disease Drug Market Development Status and Trends 1.5.1 Parkinson Disease Drug Industry Development Status Analysis 1.5.2 Parkinson Disease Drug Industry Development Trends Analysis 2 Parkinson Disease Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Parkinson Disease Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Parkinson Disease Drug Market Analysis by Regions 4.1 Parkinson Disease Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global Parkinson Disease Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Parkinson Disease Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global Parkinson Disease Drug Revenue Forecast by Region (2025-2030) 5 Global Parkinson Disease Drug Market Size by Type and Application 5.1 Global Parkinson Disease Drug Market Size by Type 5.2 Global Parkinson Disease Drug Market Size by Application 6 North America 6.1 North America Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Parkinson Disease Drug Market Size by Type 6.4 North America Parkinson Disease Drug Market Size by Application 6.5 North America Parkinson Disease Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Parkinson Disease Drug Market Size by Type 7.4 Europe Parkinson Disease Drug Market Size by Application 7.5 Europe Parkinson Disease Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Parkinson Disease Drug Market Size by Type 8.4 China Parkinson Disease Drug Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Parkinson Disease Drug Market Size by Type 9.4 APAC (excl. China) Parkinson Disease Drug Market Size by Application 9.5 APAC (excl. China) Parkinson Disease Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Parkinson Disease Drug Market Size by Type 10.4 Latin America Parkinson Disease Drug Market Size by Application 10.5 Latin America Parkinson Disease Drug Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Parkinson Disease Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Parkinson Disease Drug Market Size by Type 11.4 Middle East & Africa Parkinson Disease Drug Market Size by Application 11.5 Middle East & Africa Parkinson Disease Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Parkinson Disease Drug Market Revenue by Key Manufacturers (2020-2024) 12.2 Parkinson Disease Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 Parkinson Disease Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Merck 13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Merck Parkinson Disease Drug Product Portfolio 13.1.3 Merck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Akorn 13.2.1 Akorn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Akorn Parkinson Disease Drug Product Portfolio 13.2.3 Akorn Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 GSK 13.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 GSK Parkinson Disease Drug Product Portfolio 13.3.3 GSK Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Novartis 13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Novartis Parkinson Disease Drug Product Portfolio 13.4.3 Novartis Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Boehringer Ingelheim 13.5.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Portfolio 13.5.3 Boehringer Ingelheim Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Teva Pharmaceutical 13.6.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Portfolio 13.6.3 Teva Pharmaceutical Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Abbvie 13.7.1 Abbvie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Abbvie Parkinson Disease Drug Product Portfolio 13.7.3 Abbvie Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Kyowa Hakko Kirin Pharma 13.8.1 Kyowa Hakko Kirin Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Portfolio 13.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Astellas Pharma 13.9.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Astellas Pharma Parkinson Disease Drug Product Portfolio 13.9.3 Astellas Pharma Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Desitin Arzneimittel 13.10.1 Desitin Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Portfolio 13.10.3 Desitin Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Endo Pharmaceuticals 13.11.1 Endo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Portfolio 13.11.3 Endo Pharmaceuticals Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 F.Hoffmann-La Roche 13.12.1 F.Hoffmann-La Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Portfolio 13.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Valeant 13.13.1 Valeant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Valeant Parkinson Disease Drug Product Portfolio 13.13.3 Valeant Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 H.Lundbeck 13.14.1 H.Lundbeck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 H.Lundbeck Parkinson Disease Drug Product Portfolio 13.14.3 H.Lundbeck Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Apokyn 13.15.1 Apokyn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Apokyn Parkinson Disease Drug Product Portfolio 13.15.3 Apokyn Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Orion 13.16.1 Orion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Orion Parkinson Disease Drug Product Portfolio 13.16.3 Orion Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.17 Stada Arzneimittel 13.17.1 Stada Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 Stada Arzneimittel Parkinson Disease Drug Product Portfolio 13.17.3 Stada Arzneimittel Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.18 US WorldMeds 13.18.1 US WorldMeds Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.18.2 US WorldMeds Parkinson Disease Drug Product Portfolio 13.18.3 US WorldMeds Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.19 Bausch Health 13.19.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.19.2 Bausch Health Parkinson Disease Drug Product Portfolio 13.19.3 Bausch Health Parkinson Disease Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Parkinson Disease Drug Industry Chain Analysis 14.2 Parkinson Disease Drug Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Parkinson Disease Drug Typical Downstream Customers 14.4 Parkinson Disease Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support